SENSEX NIFTY
Home » News » Announcements
Jul 22, 2013, 03.48 PM IST | Source: Moneycontrol.com

Lupin receives FDA approval for Generic GIumetza extended-release tablets

Lupinís US subsidiary, Lupin Pharmaceuticals, Inc (LPI) has received final approval for its Metformin Hydrochloride extended release tablets 500 mg and 1000 mg from United States Food and Drugs Administration.

Lupin Ltd has informed BSE regarding a Press Release dated July 22, 2013, titled "Lupin receives FDA approval for Generic GIumetza extended-release Tablets" Lupinís US subsidiary, Lupin Pharmaceuticals, Inc (LPI) has received final approval for its Metformin Hydrochloride extended release tablets 500 mg and 1000 mg from United States Food and Drugs Administration.Source : BSE

Read all announcements in Lupin

To read the full report click here

Set email alert for

ADS BY GOOGLE

video of the day

All portents good; optimistic for next few Diwali's: Damani

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.